John V. Oyler

Co-Founder at BeiGene Ltd.

John V. Oyler

John V. Oyler

Co-Founder at BeiGene Ltd.

Overview
Career Highlights

BeiGene USA, Inc.
Galenea Corp.
Genta, Inc.

RelSci Relationships

1732

Primary Location

Beijing, China

Number of Boards

4

Birthday

1968

Age

53

Relationships
RelSci Relationships are individuals John V. Oyler likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at BeiGene Ltd.

Relationship likelihood: Strong

Senior Vice President & Head of Global Research, Clinical Operation & Biometrics & Asia Pacific Clinical Development at BeiGene Ltd.

Relationship likelihood: Strong

Partner at Hillhouse Capital Group Ltd.

Relationship likelihood: Strong

Senior Vice President, Global Head of Regulatory Affairs at BeiGene Ltd.

Relationship likelihood: Strong

Head of International Investments at Baker Bros. Advisors LP

Relationship likelihood: Strong

Secretary, General Counsel & Senior Vice President at BeiGene Ltd.

Relationship likelihood: Strong

Partner at Baker Bros. Advisors LP

Relationship likelihood: Strong

Fund Advisor at Grantham, Mayo, Van Otterloo & Co. LLC

Relationship likelihood: Strong

Former Investment Manager at The Goldman Sachs Group, Inc.

Relationship likelihood: Strong

Senior Vice President & Head of Chemistry & Manufacturing Controls at BeiGene Ltd.

Relationship likelihood: Strong

Paths to John V. Oyler
Potential Connections via
Relationship Science
You
John V. Oyler
Co-Founder at BeiGene Ltd.
Career History
Co-Founder
2010 - Current

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Founder
Current

BeiGene (Beijing) Co., Ltd., part of BeiGene Ltd., is a company headquartered in Beijing, China, that develops pharmaceuticals.

President, Chief Executive Officer, Chief Financial Officer, Secretary & Director
Current

BeiGene USA, Inc. engages in pharmaceutical development. The company is headquartered in Cambridge, MA.

Transactions
Details Hidden

BeiGene Ltd. issued USD American Depositary Shares

Investments
Details Hidden

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. It focuses on Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317), and Pamiparib (BGB-290). The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Beijing, China.

Details Hidden

Telephia, Inc. provides consulting services to the wireless industries. It offers syndicated performance measurement information to the converging communications and mobile industries. The company uses its unique measurement tools and large scale consumer panels to completely understand the digital consumer's behavior, attitudes and experience. Telephia portfolio of marketing and service quality information products helps clients to make better business decisions. The company was founded in 1999 and is headquartered in San Francisco, CA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by John V. Oyler. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of John V. Oyler's profile does not indicate a business or promotional relationship of any kind between RelSci and John V. Oyler.